A novel meta-analysis approach of cancer transcriptomes reveals prevailing transcriptional networks in cancer cells

Atsushi Niida1, Seiya Imoto, Masao Nagasaki

  • 1Human Genome Center, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. aniida@ims.u-tokyo.ac.jp

Insights

We developed a computational method, Expression Exploration Modules (EEM), to predict cancer transcriptional networks. This approach reveals a common cancer network involving cell-cycle and immune functions across diverse tumor types.

Area of Science:

  • Computational Biology
  • Cancer Genomics
  • Systems Biology

Background:

  • Microarray technology has identified transcriptomic variations in cancer.
  • Transcriptional programs driving these variations remain poorly understood.
  • Existing methods lack comprehensive analysis of cancer transcriptomes.

Purpose of the Study:

  • To develop and apply a computational method for predicting cancer transcriptional networks.
  • To elucidate the regulatory mechanisms underlying cancer phenotypes.
  • To identify common transcriptional programs across various cancer types.

Main Methods:

  • Extended the Expression Exploration Modules (EEM) computational method.
  • EEM identifies expression modules from gene sets based on biological knowledge (e.g., TF binding motifs).
  • Applied EEM to 122 public microarray datasets (approx. 15,000 experiments) from diverse cancer tissues.

Main Results:

  • Successfully predicted cancer transcriptional networks.
  • Identified a prevailing cancer transcriptional network present in a large fraction of transcriptomes.
  • Discovered cell-cycle and immune-related sub-networks within the prevailing network.

Conclusions:

  • The EEM approach is broadly applicable for predicting cancer transcriptional networks.
  • This study provides a comprehensive understanding of transcriptional regulation in cancer.
  • Opens new avenues for investigating cancer biology through network analysis.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...